Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes (vol 14, 118, 2015)

被引：0
|
作者：
Monnier, Vincent M. [1 ,2 ]
Sun, Wanjie [3 ]
Gao, Xiaoyu [3 ]
Sell, David R. [1 ]
Cleary, Patricia A. [3 ]
Lachin, John M. [3 ]
Genuth, Saul [4 ]
机构：
[1] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA
[3] George Washington Univ, Biostat Ctr, Rockville, MD USA
[4] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA
来源：
CARDIOVASCULAR DIABETOLOGY | 2015年 / 14卷
关键词：
D O I：
10.1186/s12933-015-0295-z
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 47 条
  • [1] Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes
    Vincent M Monnier
    Wanjie Sun
    Xiaoyu Gao
    David R Sell
    Patricia A Cleary
    John M Lachin
    Saul Genuth
    Cardiovascular Diabetology, 14
  • [2] Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes
    Monnier, Vincent M.
    Sun, Wanjie
    Gao, Xiaoyu
    Sell, David R.
    Cleary, Patricia A.
    Lachin, John M.
    Genuth, Saul
    CARDIOVASCULAR DIABETOLOGY, 2015, 14
  • [3] Erratum to: Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes
    Vincent M Monnier
    Wanjie Sun
    Xiaoyu Gao
    David R Sell
    Patricia A Cleary
    John M Lachin
    Saul Genuth
    Cardiovascular Diabetology, 14
  • [4] Skin collagen advanced glycation endproducts (AGEs) as prospective markers of sub-clinical cardiovascular disease (CVD) outcomes in type 1 diabetes
    Monnier, V. M.
    Sun, W.
    Sell, D. R.
    Cleary, P. A.
    Lachin, J. M.
    Genuth, S. M.
    DIABETOLOGIA, 2013, 56 : S14 - S14
  • [5] The pecking order of skin Advanced Glycation Endproducts (AGEs) as long-term markers of glycemic damage and risk factors for micro- and subclinical macrovascular disease progression in Type 1 diabetes
    Monnier, Vincent M.
    Genuth, Saul
    Sell, David R.
    GLYCOCONJUGATE JOURNAL, 2016, 33 (04) : 569 - 579
  • [6] The pecking order of skin Advanced Glycation Endproducts (AGEs) as long-term markers of glycemic damage and risk factors for micro- and subclinical macrovascular disease progression in Type 1 diabetes
    Vincent M. Monnier
    Saul Genuth
    David R. Sell
    Glycoconjugate Journal, 2016, 33 : 569 - 579
  • [7] Skin Advanced Glycation Endproducts (AGEs) are Increased at Onset in Children With Type 1 Diabetes (T1D)
    Baez, Eileen
    Shah, Shreepal
    Felipe, Dania
    Maynard, John D.
    Hempe, James
    Chalew, Stuart
    DIABETES, 2013, 62 : A349 - A349
  • [8] Familial Association of Skin Advanced Glycation Endproducts (AGEs) in Youth With Type 1 Diabetes (T1D)
    Baez, Eileen
    Shah, Shreepal
    Felipe, Dania
    Maynard, John D.
    Hempe, James
    Chalew, Stuart
    DIABETES, 2013, 62 : A353 - A353
  • [9] Skin Advanced Glycation End Products Glucosepane and Methylglyoxal Hydroimidazolone Are Independently Associated With Long-term Microvascular Complication Progression of Type 1 Diabetes
    Genuth, Saul
    Sun, Wanjie
    Cleary, Patricia
    Gao, Xiaoyu
    Sell, David R.
    Lachin, John
    Monnier, Vincent M.
    DIABETES, 2015, 64 (01) : 266 - 278
  • [10] New Collagen-Linked Advanced Glycation Endproducts (AGEs) Predict Microvascular (MV) Disease Progression Risk in Type 1 Diabetes-16 Years after the Diabetes Control and Complication Trial (DCCT)
    Monnier, Vincent M.
    Sun, Wanjie
    Sell, David R.
    Strauch, Christopher M.
    Cleary, Patricia A.
    Lachin, John M.
    Genuth, Saul
    DIABETES, 2012, 61 : A18 - A18
12345